Marc Nash - 15 May 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: SVP Operations and R&D
Signature: By: John L Brottem For: Marc Nash
Issuer symbol: OM
Transactions as of: 15 May 2025
Net transactions value: -$4,491
Form type: 4
Filing time: 16 May 2025, 17:22:58 UTC
Previous filing: 19 Feb 2025
Next filing: 11 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nash Marc	SVP Operations and R&D	3052 ORCHARD DRIVE, SAN JOSE	By: John L Brottem For: Marc Nash	16 May 2025	0001983815

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Sale	$4,491	-252	-1.8%	$17.82	13,465	15 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c).

Content

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c).